Details of the Drug Formulations

General Information of Drug (ID: DMDBX5F)

Drug Name
Ivermectin Drug Info
Synonyms I 8898; Ivexterm (TN); MK-933; Mectizan (TN); Stromectol (TN)
Indication
Disease Entry ICD 11 Status REF
Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [1]
Onchocerciasis 1F6A Approved [2]
Strongyloidiasis Approved [3]
Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2/3 [4]
Therapeutic Class
Antiprotozoal Agents
Cross-matching ID
PubChem CID
6321424
ChEBI ID
CHEBI:63941
CAS Number
71827-03-7
TTD ID
D09YHJ
VARIDT ID
DR00147
INTEDE ID
DR0899
ACDINA ID
D00340

Full List of Drug Formulations Containing This Drug

Ivermectin 3 mg tablet
Company Formulation ID FDA Description
Department of State Health Services, Pharmacy Branch; Merck Sharp & Dohme F10913 Anhydrous citric acid; Magnesium stearate; Butylated hydroxyanisole; Cellulose, microcrystalline; Starch, corn
Bryant Ranch Prepack; Central Texas Community Health Centers; Edenbridge Pharmaceuticals F10914 Magnesium stearate; Croscarmellose sodium; Silicon dioxide; Microcrystalline cellulose; Starch, corn
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2373).
2 FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (NDA) 202736
3 Ivermectin FDA Label
4 ClinicalTrials.gov (NCT04351347) The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment. U.S. National Institutes of Health.